Global Professional Diagnostics

Professional Diagnostics Comprehensive Study by Type (Immunochemistry, Clinical Microbiology, Point of Care Test (POCT), Haematology, Haemostasis), Application (Hospitals, Diagnostic Laboratories, Others), Prescription Mode (Prescription-Based Testing, OTC Testing) Players and Region - Global Market Outlook to 2027

Professional Diagnostics Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 6.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Professional Diagnostics
The range of diseases which affect and afflict humans continues to hamper development in many parts of the world. From communicable diseases to non-communicable diseases, genetic diseases to lifestyle-related and behavioural diseases, those induced by hardship and by poverty to those induced by affluence, and those which result from natural and man-made disasters. The professional diagnostic services provide physicians with a wide range of tools to help in their decision-making regarding appropriate treatment of all types of disease for their patients. At the same time, health technology is becoming more and more sophisticated throughout the world, containing many parts of the developing world. However, the professional diagnostics, whether by laboratory services or imaging services, becomes more expensive every year.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
CAGR6.8%


Analyst at AMA Research estimates that European Players will contribute the maximum growth to Global Professional Diagnostics market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), A. Menarini Diagnostics (Italy), ARKRAY, Inc. (Japan), Abaxis, Inc. (United States), Abbott Diagnostics (United States), Bio-Rad Laboratories (United States), Biocartis (Belgium), CellaVision (Sweden) and Cepheid (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are DiagCor Bioscience Incorporation Limited (Hong Kong), Drucker Diagnostics (United States), EKF Diagnostics (United Kingdom) and Erba Diagnostics (United States).

Segmentation Overview
AMA Research has segmented the market of Global Professional Diagnostics market by Type (Immunochemistry, Clinical Microbiology, Point of Care Test (POCT), Haematology and Haemostasis), Application (Hospitals, Diagnostic Laboratories and Others) and Region.



On the basis of geography, the market of Professional Diagnostics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Prescription Mode, the sub-segment i.e. Prescription-Based Testing will boost the Professional Diagnostics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Leasing and Renting of Professional Diagnostics Instruments and Growing Incidence of Target Diseases

Market Growth Drivers:
Increasing Focus on Diagnosing Life-Threatening Conditions and High Prevalence of Infectious Diseases in Developing Nations

Challenges:
High Cost of Devices

Restraints:
Stringent and Time-Consuming Regulatory Policies

Opportunities:
Technological Advancements and New Product Launches and Growing Governmental Support

On Feb 5, 2019 - The CellaVision® DC-1 strengthens the company's global position and opens a new segment of the market comprising about 100,000 small and mid-sized laboratories.
Under the Medical Device User Fee and Modernization Act (MDUFMA), medical device companies pay fees to the FDA when they register their establishments and list their devices with the agency, whenever they submit an application or a notification to market a new medical device in the U.S. and for certain other types of submissions. These fees help the FDA increase the efficiency of regulatory processes with a goal of reducing the time it takes to bring safe and effective medical devices to the U.S. market.

Key Target Audience
Professional Diagnostics Service Providers, Manufacturers of Diagnostic Instruments, Suppliers of Diagnostic Instruments, Healthcare Industry, Governmental Bodies and Research Firms

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Immunochemistry
  • Clinical Microbiology
  • Point of Care Test (POCT)
  • Haematology
  • Haemostasis
By Application
  • Hospitals
  • Diagnostic Laboratories
  • Others
By Prescription Mode
  • Prescription-Based Testing
  • OTC Testing

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Focus on Diagnosing Life-Threatening Conditions
      • 3.2.2. High Prevalence of Infectious Diseases in Developing Nations
    • 3.3. Market Challenges
      • 3.3.1. High Cost of Devices
    • 3.4. Market Trends
      • 3.4.1. Leasing and Renting of Professional Diagnostics Instruments
      • 3.4.2. Growing Incidence of Target Diseases
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Professional Diagnostics, by Type, Application, Prescription Mode and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Professional Diagnostics (Value)
      • 5.2.1. Global Professional Diagnostics by: Type (Value)
        • 5.2.1.1. Immunochemistry
        • 5.2.1.2. Clinical Microbiology
        • 5.2.1.3. Point of Care Test (POCT)
        • 5.2.1.4. Haematology
        • 5.2.1.5. Haemostasis
      • 5.2.2. Global Professional Diagnostics by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Diagnostic Laboratories
        • 5.2.2.3. Others
      • 5.2.3. Global Professional Diagnostics by: Prescription Mode (Value)
        • 5.2.3.1. Prescription-Based Testing
        • 5.2.3.2. OTC Testing
      • 5.2.4. Global Professional Diagnostics Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Professional Diagnostics (Price)
      • 5.3.1. Global Professional Diagnostics by: Type (Price)
  • 6. Professional Diagnostics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Roche Diagnostics (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Siemens Healthineers (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. A. Menarini Diagnostics (Italy)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. ARKRAY, Inc. (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Abaxis, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Abbott Diagnostics (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bio-Rad Laboratories (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Biocartis (Belgium)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. CellaVision (Sweden)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Cepheid (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Professional Diagnostics Sale, by Type, Application, Prescription Mode and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Professional Diagnostics (Value)
      • 7.2.1. Global Professional Diagnostics by: Type (Value)
        • 7.2.1.1. Immunochemistry
        • 7.2.1.2. Clinical Microbiology
        • 7.2.1.3. Point of Care Test (POCT)
        • 7.2.1.4. Haematology
        • 7.2.1.5. Haemostasis
      • 7.2.2. Global Professional Diagnostics by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Diagnostic Laboratories
        • 7.2.2.3. Others
      • 7.2.3. Global Professional Diagnostics by: Prescription Mode (Value)
        • 7.2.3.1. Prescription-Based Testing
        • 7.2.3.2. OTC Testing
      • 7.2.4. Global Professional Diagnostics Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Professional Diagnostics (Price)
      • 7.3.1. Global Professional Diagnostics by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Professional Diagnostics: by Type(USD Million)
  • Table 2. Professional Diagnostics Immunochemistry , by Region USD Million (2016-2021)
  • Table 3. Professional Diagnostics Clinical Microbiology , by Region USD Million (2016-2021)
  • Table 4. Professional Diagnostics Point of Care Test (POCT) , by Region USD Million (2016-2021)
  • Table 5. Professional Diagnostics Haematology , by Region USD Million (2016-2021)
  • Table 6. Professional Diagnostics Haemostasis , by Region USD Million (2016-2021)
  • Table 7. Professional Diagnostics: by Application(USD Million)
  • Table 8. Professional Diagnostics Hospitals , by Region USD Million (2016-2021)
  • Table 9. Professional Diagnostics Diagnostic Laboratories , by Region USD Million (2016-2021)
  • Table 10. Professional Diagnostics Others , by Region USD Million (2016-2021)
  • Table 11. Professional Diagnostics: by Prescription Mode(USD Million)
  • Table 12. Professional Diagnostics Prescription-Based Testing , by Region USD Million (2016-2021)
  • Table 13. Professional Diagnostics OTC Testing , by Region USD Million (2016-2021)
  • Table 14. South America Professional Diagnostics, by Country USD Million (2016-2021)
  • Table 15. South America Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 16. South America Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 17. South America Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 18. Brazil Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 19. Brazil Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 20. Brazil Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 21. Argentina Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 22. Argentina Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 23. Argentina Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 24. Rest of South America Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 25. Rest of South America Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 26. Rest of South America Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 27. Asia Pacific Professional Diagnostics, by Country USD Million (2016-2021)
  • Table 28. Asia Pacific Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 29. Asia Pacific Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 30. Asia Pacific Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 31. China Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 32. China Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 33. China Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 34. Japan Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 35. Japan Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 36. Japan Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 37. India Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 38. India Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 39. India Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 40. South Korea Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 41. South Korea Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 42. South Korea Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 43. Taiwan Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 44. Taiwan Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 45. Taiwan Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 46. Australia Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 47. Australia Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 48. Australia Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 49. Rest of Asia-Pacific Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 50. Rest of Asia-Pacific Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 51. Rest of Asia-Pacific Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 52. Europe Professional Diagnostics, by Country USD Million (2016-2021)
  • Table 53. Europe Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 54. Europe Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 55. Europe Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 56. Germany Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 57. Germany Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 58. Germany Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 59. France Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 60. France Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 61. France Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 62. Italy Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 63. Italy Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 64. Italy Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 65. United Kingdom Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 66. United Kingdom Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 67. United Kingdom Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 68. Netherlands Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 69. Netherlands Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 70. Netherlands Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 71. Rest of Europe Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 72. Rest of Europe Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 73. Rest of Europe Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 74. MEA Professional Diagnostics, by Country USD Million (2016-2021)
  • Table 75. MEA Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 76. MEA Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 77. MEA Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 78. Middle East Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 79. Middle East Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 80. Middle East Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 81. Africa Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 82. Africa Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 83. Africa Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 84. North America Professional Diagnostics, by Country USD Million (2016-2021)
  • Table 85. North America Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 86. North America Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 87. North America Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 88. United States Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 89. United States Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 90. United States Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 91. Canada Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 92. Canada Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 93. Canada Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 94. Mexico Professional Diagnostics, by Type USD Million (2016-2021)
  • Table 95. Mexico Professional Diagnostics, by Application USD Million (2016-2021)
  • Table 96. Mexico Professional Diagnostics, by Prescription Mode USD Million (2016-2021)
  • Table 97. Professional Diagnostics: by Type(USD/Units)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Professional Diagnostics: by Type(USD Million)
  • Table 109. Professional Diagnostics Immunochemistry , by Region USD Million (2022-2027)
  • Table 110. Professional Diagnostics Clinical Microbiology , by Region USD Million (2022-2027)
  • Table 111. Professional Diagnostics Point of Care Test (POCT) , by Region USD Million (2022-2027)
  • Table 112. Professional Diagnostics Haematology , by Region USD Million (2022-2027)
  • Table 113. Professional Diagnostics Haemostasis , by Region USD Million (2022-2027)
  • Table 114. Professional Diagnostics: by Application(USD Million)
  • Table 115. Professional Diagnostics Hospitals , by Region USD Million (2022-2027)
  • Table 116. Professional Diagnostics Diagnostic Laboratories , by Region USD Million (2022-2027)
  • Table 117. Professional Diagnostics Others , by Region USD Million (2022-2027)
  • Table 118. Professional Diagnostics: by Prescription Mode(USD Million)
  • Table 119. Professional Diagnostics Prescription-Based Testing , by Region USD Million (2022-2027)
  • Table 120. Professional Diagnostics OTC Testing , by Region USD Million (2022-2027)
  • Table 121. South America Professional Diagnostics, by Country USD Million (2022-2027)
  • Table 122. South America Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 123. South America Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 124. South America Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 125. Brazil Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 126. Brazil Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 127. Brazil Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 128. Argentina Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 129. Argentina Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 130. Argentina Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 131. Rest of South America Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 132. Rest of South America Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 133. Rest of South America Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 134. Asia Pacific Professional Diagnostics, by Country USD Million (2022-2027)
  • Table 135. Asia Pacific Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 136. Asia Pacific Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 137. Asia Pacific Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 138. China Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 139. China Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 140. China Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 141. Japan Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 142. Japan Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 143. Japan Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 144. India Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 145. India Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 146. India Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 147. South Korea Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 148. South Korea Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 149. South Korea Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 150. Taiwan Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 151. Taiwan Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 152. Taiwan Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 153. Australia Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 154. Australia Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 155. Australia Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 156. Rest of Asia-Pacific Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 157. Rest of Asia-Pacific Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 158. Rest of Asia-Pacific Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 159. Europe Professional Diagnostics, by Country USD Million (2022-2027)
  • Table 160. Europe Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 161. Europe Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 162. Europe Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 163. Germany Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 164. Germany Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 165. Germany Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 166. France Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 167. France Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 168. France Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 169. Italy Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 170. Italy Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 171. Italy Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 172. United Kingdom Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 173. United Kingdom Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 174. United Kingdom Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 175. Netherlands Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 176. Netherlands Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 177. Netherlands Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 178. Rest of Europe Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 179. Rest of Europe Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 180. Rest of Europe Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 181. MEA Professional Diagnostics, by Country USD Million (2022-2027)
  • Table 182. MEA Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 183. MEA Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 184. MEA Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 185. Middle East Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 186. Middle East Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 187. Middle East Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 188. Africa Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 189. Africa Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 190. Africa Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 191. North America Professional Diagnostics, by Country USD Million (2022-2027)
  • Table 192. North America Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 193. North America Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 194. North America Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 195. United States Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 196. United States Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 197. United States Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 198. Canada Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 199. Canada Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 200. Canada Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 201. Mexico Professional Diagnostics, by Type USD Million (2022-2027)
  • Table 202. Mexico Professional Diagnostics, by Application USD Million (2022-2027)
  • Table 203. Mexico Professional Diagnostics, by Prescription Mode USD Million (2022-2027)
  • Table 204. Professional Diagnostics: by Type(USD/Units)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Professional Diagnostics: by Type USD Million (2016-2021)
  • Figure 5. Global Professional Diagnostics: by Application USD Million (2016-2021)
  • Figure 6. Global Professional Diagnostics: by Prescription Mode USD Million (2016-2021)
  • Figure 7. South America Professional Diagnostics Share (%), by Country
  • Figure 8. Asia Pacific Professional Diagnostics Share (%), by Country
  • Figure 9. Europe Professional Diagnostics Share (%), by Country
  • Figure 10. MEA Professional Diagnostics Share (%), by Country
  • Figure 11. North America Professional Diagnostics Share (%), by Country
  • Figure 12. Global Professional Diagnostics: by Type USD/Units (2016-2021)
  • Figure 13. Global Professional Diagnostics share by Players 2021 (%)
  • Figure 14. Global Professional Diagnostics share by Players (Top 3) 2021(%)
  • Figure 15. Global Professional Diagnostics share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Roche Diagnostics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 18. Roche Diagnostics (Switzerland) Revenue: by Geography 2021
  • Figure 19. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Siemens Healthineers (Germany) Revenue: by Geography 2021
  • Figure 21. A. Menarini Diagnostics (Italy) Revenue, Net Income and Gross profit
  • Figure 22. A. Menarini Diagnostics (Italy) Revenue: by Geography 2021
  • Figure 23. ARKRAY, Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 24. ARKRAY, Inc. (Japan) Revenue: by Geography 2021
  • Figure 25. Abaxis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Abaxis, Inc. (United States) Revenue: by Geography 2021
  • Figure 27. Abbott Diagnostics (United States) Revenue, Net Income and Gross profit
  • Figure 28. Abbott Diagnostics (United States) Revenue: by Geography 2021
  • Figure 29. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 30. Bio-Rad Laboratories (United States) Revenue: by Geography 2021
  • Figure 31. Biocartis (Belgium) Revenue, Net Income and Gross profit
  • Figure 32. Biocartis (Belgium) Revenue: by Geography 2021
  • Figure 33. CellaVision (Sweden) Revenue, Net Income and Gross profit
  • Figure 34. CellaVision (Sweden) Revenue: by Geography 2021
  • Figure 35. Cepheid (United States) Revenue, Net Income and Gross profit
  • Figure 36. Cepheid (United States) Revenue: by Geography 2021
  • Figure 37. Global Professional Diagnostics: by Type USD Million (2022-2027)
  • Figure 38. Global Professional Diagnostics: by Application USD Million (2022-2027)
  • Figure 39. Global Professional Diagnostics: by Prescription Mode USD Million (2022-2027)
  • Figure 40. South America Professional Diagnostics Share (%), by Country
  • Figure 41. Asia Pacific Professional Diagnostics Share (%), by Country
  • Figure 42. Europe Professional Diagnostics Share (%), by Country
  • Figure 43. MEA Professional Diagnostics Share (%), by Country
  • Figure 44. North America Professional Diagnostics Share (%), by Country
  • Figure 45. Global Professional Diagnostics: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Roche Diagnostics (Switzerland)
  • Siemens Healthineers (Germany)
  • A. Menarini Diagnostics (Italy)
  • ARKRAY, Inc. (Japan)
  • Abaxis, Inc. (United States)
  • Abbott Diagnostics (United States)
  • Bio-Rad Laboratories (United States)
  • Biocartis (Belgium)
  • CellaVision (Sweden)
  • Cepheid (United States)
Additional players considered in the study are as follows:
DiagCor Bioscience Incorporation Limited (Hong Kong) , Drucker Diagnostics (United States) , EKF Diagnostics (United Kingdom) , Erba Diagnostics (United States)
Select User Access Type

Key Highlights of Report


Feb 2022 215 Pages 57 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Professional Diagnostics Quantitative research analysis
Global Professional Diagnostics Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), A. Menarini Diagnostics (Italy), ARKRAY, Inc. (Japan), Abaxis, Inc. (United States), Abbott Diagnostics (United States), Bio-Rad Laboratories (United States), Biocartis (Belgium), CellaVision (Sweden) and Cepheid (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Leasing and Renting of Professional Diagnostics Instruments " is seen as one of major influencing trends for Professional Diagnostics Market during projected period 2021-2027.
The Professional Diagnostics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Professional Diagnostics Report?

Have a Query? Click Here

Other Related Reports

Surgical Lasers Comprehensive Study by Type (Carbon Dioxide (CO2) Lasers, Argon Lasers, Diode Lasers, ND:Yag (Neodymium:Yttrium-Aluminum-Garnet) Lasers, Other Surgical Lasers), Application (Ophthalmo...
$ 3650
Bronchiectasis Treatment Comprehensive Study by Application (Clinics, Hospital, Homecare), Treatment (Medication, Exercises, Devices, Surgery), Bronchiectasis (Cylindrical Bronchiectasis, Varicose Br...
$ 3350
Stoma Care/Ostomy Care and Accessories Comprehensive Study by Type (Ostomy Care Bag (System (One, Two-Piece), Usability (Drainable, Closed), Shape (Flat, Convex)), Ostomy Care Accessories (Cleansers,...
$ 3650
Ocular Drug Delivery Comprehensive Study by Application (Bacterial Conjunctivitis, Cataract Surgery, Allergic Conjunctivitis, Retinal Vein Occlusion, Bulbar Conjunctiva, Sympathetic Ophthalmia), Dise...
$ 3750
Pharmerging Comprehensive Study by Type (Pharmaceuticals, Healthcare), Distribution Channel (Hospitals, Retail Pharmacies, Online Stores, Others), Indications (Lifestyle Diseases, Cancer and Autoimmu...
$ 3800
3D Medical Printing Systems Comprehensive Study by Type (Surgical Guides, Dental Guides, Craniomaxillofacial Guides, Orthopedic Guides, Surgical Instruments, Retractors, Others), Application (Hospita...
$ 3750